Bibliographie (2546)
M-A: Global prevalence of post COVID-19 condition or long COVID.
mardi, 19 avril 2022 07:30 Écrit par Zouhair SouissiGlobal Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review – The Journal of Infectious Diseases Commentary: Global data reveal half may have long COVID 4 months on – CIDRAP Commentary on Twitter (thread – click for more) ?The so far largest meta-analysis of more than 1.5 million infected individuals […]
The post M-A: Global prevalence of post COVID-19 condition or long COVID. appeared first on Links Medicus.
Review: Covid-19: virology, variants, and vaccines.
lundi, 18 avril 2022 13:58 Écrit par Zouhair SouissiCovid-19: virology, variants, and vaccines – BMJ Medicine Commentary on Twitter ? New review on #COVID: virology, variants and vaccines by Megan Young, Harry Crook, Janet Scott and Paul Edison from @ImperialMed ➡️ Read it now! https://t.co/hYrCQYVvNr#BMJMedicine #MedTwitter pic.twitter.com/aGA0DsX38K — BMJMedicine (@BMJMedicine) April 14, 2022
The post Review: Covid-19: virology, variants, and vaccines. appeared first on Links Medicus.
Cross-sectional study: evaluating prediction models of sleep apnea from smartphone-recorded sleep breathing sounds.
lundi, 18 avril 2022 12:50 Écrit par Zouhair SouissiEvaluating Prediction Models of Sleep Apnea From Smartphone-Recorded Sleep Breathing Sounds – JAMA Otolaryngology-Head & Neck Surgery (link to abstract – for full-text) Commentary on Twitter Study found, smartphone-recorded #sleep breathing sounds may be used to create prediction models for obstructive sleep apnea, but additional verification of real-life recordings using various smartphone devices should […]
The post Cross-sectional study: evaluating prediction models of sleep apnea from smartphone-recorded sleep breathing sounds. appeared first on Links Medicus.
Incidental discovery of interstitial lung disease: diagnostic approach, surveillance and perspectives.
lundi, 18 avril 2022 12:50 Écrit par Zouhair SouissiIncidental discovery of interstitial lung disease: diagnostic approach, surveillance and perspectives – European Respiratory Review
The post Incidental discovery of interstitial lung disease: diagnostic approach, surveillance and perspectives. appeared first on Links Medicus.
A randomized controlled trial explored the safety and tolerability of Sulthiame in sleep apnea.
lundi, 18 avril 2022 12:50 Écrit par Zouhair SouissiA Randomized Controlled Trial Exploring Safety and Tolerability of Sulthiame in Sleep Apnea – American Journal of Respiratory and Critical Care Medicine News Release: Drug reduced frequency of breathing pauses in sleep apnea – University of Gothenburg Commentary on Twitter In a four-week trial of patients with OSA not tolerating PAP therapy, researchers found […]
The post A randomized controlled trial explored the safety and tolerability of Sulthiame in sleep apnea. appeared first on Links Medicus.
The Lancet Series: Origins of chronic obstructive pulmonary disease.
jeudi, 14 avril 2022 11:58 Écrit par Zouhair SouissiHomepage: Origins of chronic obstructive pulmonary disease – The Lancet Respiratory Medicine (free registration required for all articles) Genetics of chronic obstructive pulmonary disease: understanding the pathobiology and heterogeneity of a complex disorder Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment Pathogenesis of chronic obstructive pulmonary disease: understanding […]
The post The Lancet Series: Origins of chronic obstructive pulmonary disease. appeared first on Links Medicus.
A nationwide observational analysis in Israel showed a fourth dose of the Pfizer vaccine may reduce the short-term risk of Covid-19–related outcomes.
jeudi, 14 avril 2022 11:58 Écrit par Zouhair SouissiFourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting – New England Journal of Medicine Editorial: Covid-19 Boosters — Where from Here? Related: COVID-19: Joint statement from ECDC and EMA on the administration of a fourth dose of mRNA vaccines. Observational study suggests a fourth dose of the Pfizer vaccine provided additional protection […]
The post A nationwide observational analysis in Israel showed a fourth dose of the Pfizer vaccine may reduce the short-term risk of Covid-19–related outcomes. appeared first on Links Medicus.
Covid-19: What is the evidence for the antiviral molnupiravir?
jeudi, 14 avril 2022 11:58 Écrit par Zouhair SouissiCovid-19: What is the evidence for the antiviral molnupiravir? – The BMJ
The post Covid-19: What is the evidence for the antiviral molnupiravir? appeared first on Links Medicus.
Drug resistant TB – latest developments in epidemiology, diagnostics and management.
mercredi, 13 avril 2022 15:39 Écrit par Zouhair SouissiDrug resistant TB – latest developments in epidemiology, diagnostics and management – International Journal of Infectious Diseases Related: Summary | WHO recommendations on the treatment of drug-resistant tuberculosis, 2020 update. WHO Consolidated Guidelines on Drug-resistant Tuberculosis Treatment Randomized Trial: 9-month Treatment for Multi-drug Resistant TB is as Effective as 24-month Treatment Canadian Tuberculosis Standards – […]
The post Drug resistant TB – latest developments in epidemiology, diagnostics and management. appeared first on Links Medicus.
Review: Diagnosis and treatment of pulmonary arterial hypertension.
mercredi, 13 avril 2022 15:39 Écrit par Zouhair SouissiDiagnosis and Treatment of Pulmonary Arterial Hypertension: A Review – JAMA (free for a limited period) Audio Clinical Review: Diagnosis and Treatment of Pulmonary Arterial Hypertension – JAMA Commentary on Twitter This review summarizes current evidence regarding diagnosis and treatment of pulmonary arterial #hypertension. https://t.co/Ebo33PD8Qq — JAMA (@JAMA_current) April 12, 2022
The post Review: Diagnosis and treatment of pulmonary arterial hypertension. appeared first on Links Medicus.
